
Aparna Ramasubramanian MD
Pediatric & Strabismus
Director of Retinoblastoma, Children's Wisconsin
Join to View Full Profile
9000 W Wisconsin AveMilwaukee, WI 53226
Phone+1 414-266-2020
Fax+1 414-266-2027
Dr. Ramasubramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a pediatric ophthalmologist and ocular oncologist working at Children's Wisconsin. My clinical and research interest is retinoblastoma.
Education & Training
Indiana University School of MedicineResidency, Ophthalmology, 2011 - 2014
St Vincent HospitalResidency, Internal Medicine, 2009 - 2010
University of Kerala Medical CollegeClass of 2003
Certifications & Licensure
WI State Medical License 2023 - 2027
AZ State Medical License 2019 - 2026
KY State Medical License 2015 - 2020
UT State Medical License 2014 - 2016
PA State Medical License 2012 - 2014
American Board of Ophthalmology Ophthalmology
Clinical Trials
- Topotecan Episcleral Plaque for Treatment of Retinoblastoma Start of enrollment: 2021 Jun 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsChoroidal Hemangioma Treatment with Propranolol - A Case Study in Sturge-Weber Syndrome and Systematic Literature Review.Suma Thareja, Elizabeth Lucero, Aparna Ramasubramanian
Seminars in Ophthalmology. 2025-10-01 - Drug Delivery in Retinoblastoma.Steven Trinh, Amit Joshi, Shyam S Chaurasia, Aparna Ramasubramanian
International Ophthalmology Clinics. 2025-10-01 - Cavitary retinoblastoma with MYCN amplification.Kathryn E Tobert, Nicole Liberio, Kerri Becktell, Aparna Ramasubramanian
Journal of AAPOS. 2025-08-09
Press Mentions
Eye Mobile Units and Their Effect on Access to Pediatric Eye CareSeptember 1st, 2024
Fewer Pediatric Ophthalmologists and an Uneven Distribution Affect Access to Pediatric CareSeptember 1st, 2024
Bevacizumab for Retinopathy of Prematurity Is Not Associated with Systemic HypertensionAugust 14th, 2024- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









